Search results for "Opioids"
Q&A: DEA requires addiction training for all prescribers
The Drug Enforcement Administration is requiring eight hours of training related to substance use disorder treatment, sending clinicians scurrying to their continuing education providers for help.
https://immattersacp.org/archives/2023/05/dea-requires-addiction-training-for-all-prescribers.htm
1 May 2023
ACP's Pain Management Learning Hub releases new learning materials
Each of the new peer-to-peer activities provides opportunities for ACP members to earn free CME/MOC credit and meet many state-based CME requirements.
https://immattersacp.org/weekly/archives/2022/02/01/6.htm
1 Feb 2022
‘Considerable uncertainty’ surrounds efficacy, safety of analgesics for low back pain
A systematic review and meta-analysis of 98 randomized controlled trials found little high-certainty evidence on the comparative effectiveness and safety of analgesics for acute nonspecific low back pain.
https://immattersacp.org/weekly/archives/2023/03/28/1.htm
28 Mar 2023
Illicitly manufactured fentanyls involved in increasing number of U.S. overdose deaths
From July 2019 to December 2020, sharp increases were seen in deaths involving illicitly manufactured fentanyls in midwestern (33.1%), southern (64.7%), and western (93.9%) jurisdictions, federal data indicate.
https://immattersacp.org/weekly/archives/2021/12/21/4.htm
21 Dec 2021
Reproductive-age women widely prescribed opioid medications
Opioid-containing medications are widely prescribed among reproductive-age women with either private insurance or Medicaid, with approximately one-fourth of privately insured and more than one-third of Medicaid-enrolled women filling a prescription for an opioid each year from 2008 to 2012.
https://immattersacp.org/weekly/archives/2015/02/03/2.htm
3 Feb 2015
MKSAP Quiz: Evaluation for low back pain
A 47-year-old man is evaluated for low back pain. The pain began 5 days ago while he was playing basketball. It is localized to the lumbar back and does not radiate. The patient is unable to sit or stand for long periods, but the pain improves when lying down. After a physical exam, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2022/05/17/4.htm
17 May 2022
ACP course helps prescribers safely prescribe opioids, meet FDA requirements
The FDA requires a Risk Evaluation and Mitigation Strategy (REMS) for all brand and generic extended-release (ER) and long-acting (LA) opioid pain medicines to ensure that the benefits of prescribing a drug outweigh its risks for patients.
https://immattersacp.org/weekly/archives/2014/09/30/11.htm
30 Sep 2014
Treatment pathways compared for diabetic peripheral neuropathy
Amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin were similarly effective for controlling pain, a recent study found.
https://immattersacp.org/weekly/archives/2022/08/30/2.htm
30 Aug 2022
Neurologists suggest steps for prescribing opioids for chronic pain
The American Academy of Neurology issued a position paper outlining steps that can help physicians who prescribe chronic opioid analgesic therapy (COAT) for chronic noncancer pain (CNCP).
https://immattersacp.org/weekly/archives/2014/10/07/1.htm
7 Oct 2014
Breaking barriers to buprenorphine
Despite heightened awareness of the opioid crisis, treatment still eludes many patients who are struggling with addiction.
https://immattersacp.org/archives/2018/09/breaking-barriers-to-buprenorphine.htm
1 Sep 2018